Epidermodysplasia verruciformis: An unusual presentation

Dermatologic Surgery

Volumn 32, Issue 2, 2006, Pages 302-306

  Ortak, Turgut ^a   Uysal, Ahmet Cagri ^b   Alagoz, Murat Sahin ^c   Orbay, Hakan ^a   Sensoz, Omer ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c KOCAELI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; EPIDERMODYSPLASIA VERRUCIFORMIS; EXCISION; FAMILY HISTORY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; SKIN CARCINOMA; SKIN GRAFT; SKIN SURGERY; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; HUMANS; MALE; SKIN NEOPLASMS; SKIN TRANSPLANTATION;

EID: 33645092935     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2006.32056.x     Document Type: Article

References (15)

1. Micalli G Nasca MR Dall'oglio F Musumeci ML. Cimetine therapy for epidermodysplasia verruciformis J Am Acad Dermatol 2003 48 9 10
2. Mizutani H Shirakata Y Adachi A Hashimoto K Masayuki S. Cultured epidermal sheet graft for epidermodysplasia verruciformis Lancet 1998 352 709
3. Anadolu R Oskay T Erdem C Boyvat A Terzi E Gürgey E. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a J Am Acad Dermatol 2001 45 296 9
4. Gunma M. Malignant proliferating trichilemmal tumour associated with human papillomavirus type 21 in epidermodysplasia verruciformis Bri J Dermatol 2003 148 171 92
5. Weber BP Fierlbeck G Kempf HG. Multiple metachronous skin squamous cell carcinomas and epidermodysplasia verruciformis in the head region a human papillomavirus associated disease Eur Arch Otorhinolaryngol 1994 251 342 6
6. Belinkie SA Swartz WM Zitelli JA. Invasive squamous cell carcinoma of the carpus malignant transformation of epidermis dysplasia verruciformis J Hand Surg 1986 11A 273 5
7. Nuovo GJ Ishag M. The histologic spectrum of epidermodysplasia verruciformis Am J Surg Pathol 2000 24 1400 6
8. Majewski S Jablonska S. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations Arch Dermatol 2002 138 649 54
9. Padlewska K Ramoz N Cassonnet P et al Mutation and abnormal expression of the p53 gene in the viral skin carcinogenesis of epidermodysplasia verruciformis J Invest Dermatol 2001 117 935 42
10. Akgül B Karle P Adam M Fuchs PG Pfister HJ. Dual role of tumor suppressor p53 in regulation of DNA replication and oncogene E6-promoter activity of epidermodysplasia verruciformis associated human papillomavirus type 8 Virology 2003 308 279 90
11. Boxman ILA Russell A Mulder LHC Bavinck JNB Schegget JT Gren A. Association between epidermodysplasia verruciformis associated human papillomavirus DNA in plucked eyebrow hair and solar keratosis J Invest Dermatol 2001 17 1108 12
12. Boxman ILA Mulder LHC Noya F et al Transduction of the E6 and E7 genes of epidermodysplasia verruciformis associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures J Invest Dermatol 2001 117 1397 404
13. Lutzner MA Bardon CB. Oral retinoid treatment of human papillomavirus type 5-induced epidermodysplasia verruciformis N Eng J Med 1980 302 1091
14. Kanerva LO Johansson E Niemi KM Lauharanta J Salo OP. Epidermodysplasia verruciformis: clinical and light and electron microscopic observations during etretinate therapy Arch Dermatol Res 1985 278 153 60
15. Tanigaki T Kanda R. Severe intractable common warts associated with human papillomavirus 2, 3 and 20 Dermatology 1990 181 159 61